Duck hepatitis virus (DHV) I type VP1 protein inhibitory peptide and application thereof
A duck hepatitis virus, protein inhibition technology, applied in the direction of application, antiviral agent, peptide/protein composition, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] The screening of duck hepatitis virus type I VP1 protein inhibitory peptide in the present embodiment comprises the following steps:
[0024] (1) Preparation of DHV-1VP1 protein
[0025] 1) Construction of expression vector pET32a-VP1
[0026] According to the VP1 gene sequence (serial number: EF653378) of DHV-1 published by GenBank, use DNAStar software to analyze, design a pair of specific primers, primer F15' end introduces EcoR I restriction enzyme site, F25' end introduces Xba I restriction enzyme site. Primers were synthesized by Dalian Bao Biological Engineering Company.
[0027] The primer sequences are as follows:
[0028] F1:5'-CCAGAATTCGGTGATTCTAACCAG-3' (as shown in SEQ ID NO:2);
[0029] F2: 5'-GTTTCTAGATTCAATTTCCAG-3' (such as SEQ ID NO.3).
[0030] Duck hepatitis virus type I VJ strain is known to be isolated from a diseased duck farm, and determined to be type I duck hepatitis virus through sequence determination and evolution analysis, and its geno...
Embodiment 2
[0058] In this embodiment, the application of duck hepatitis virus type I VP1 protein inhibitory peptide in the preparation of anti-duck hepatitis virus disease medicine includes the following steps: adopt solid phase synthesis to synthesize duck hepatitis virus type I VP1 protein inhibitory peptide, purify, freeze-dry , mixed with commonly used auxiliary materials starch, sucrose and talcum powder in the field of medicine to prepare tablet medicine for resisting duck hepatitis virus disease. The duck hepatitis virus type I VP1 protein inhibitory peptide is used as the main antiviral active ingredient in the antiviral drug, the content of each tablet of the main drug is 0.1 g, and the mass percentage of the main drug is 50%.
Embodiment 3
[0060] In this embodiment, the application of the duck hepatitis virus type I VP1 protein inhibitory peptide in the preparation of feed additives against duck hepatitis virus disease comprises the following steps: after the duck hepatitis virus type I VP1 protein inhibitory peptide is purified, it is freeze-dried to obtain a purity of 95 More than % of the polypeptide powder, to get. 0.2-0.5‰ duck hepatitis virus type I VP1 protein inhibitory peptide can be added according to the feed weight, that is, 200-500 grams of peptides can be added per ton of feed.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com